Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-11-24-Speech-3-963"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2010-11-24"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"pt"^^xsd:language2
lpv:document identification number	"en.20101124.15.3-963"2
lpv:hasSubsequent	lp_eu:2010-11-24-Speech-3-9622
lpv:speaker	lp:Nuno Melo2
lpv:spokenAs	member_of_the_bureau; EPP (2009-07-14--2014-06-30)3 member; LIBE (2009-07-16--2012-01-18)3 vice-chair; Delegation for relations with the Mercosur countries (2009-09-30--2014-06-30)3 substitute; Delegation for relations with the Palestinian Legislative Council (2009-09-16--2014-06-30)3 substitute; DROI (2009-07-16--2012-01-18)3 unknown; Partido Popular (2009-07-14--2014-06-30)3 substitute; ECON (2009-07-16--2012-01-18)3 member; Delegation to the Euro-Latin American Parliamentary Assembly (2009-09-16--2014-06-30)3
lpv:translated text	"Access to quality information relating to medicinal products that are subject to medical prescription will contribute to achieving better results in terms of patient health, in that the better informed they are, the more likely they will be to better understand decisions related to their treatment. Therefore, the objective of this proposal cannot be limited to harmonising European legislation, but should also promote health, through the improvement of knowledge in the area of health. The pharmaceutical industry has an important role to play in the promotion of literacy in the area of health, but this role should be clearly defined, and participation by the sector strictly regulated, in order to prevent commercial considerations from leading to an excessive consumption of medicines."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph